General Information of Drug Off-Target (DOT) (ID: OTKNFPUY)

DOT Name Cysteine and tyrosine-rich protein 1 (CYYR1)
Synonyms Proline-rich domain-containing protein
Gene Name CYYR1
Related Disease
Neoplasm ( )
Neuroendocrine neoplasm ( )
UniProt ID
CYYR1_HUMAN
3D Structure
Download
2D Sequence (FASTA)
Download
3D Structure (PDB)
Download
Pfam ID
PF10873
Sequence
MDAPRLPVRPGVLLPKLVLLFVYADDCLAQCGKDCKSYCCDGTTPYCCSYYAYIGNILSG
TAIAGIVFGIVFIMGVIAGIAICICMCMKNHRATRVGILRTTHINTVSSYPGPPPYGHDH
EMEYCADLPPPYSPTPQGPAQRSPPPPYPGNARK
Tissue Specificity Widely expressed.

Molecular Interaction Atlas (MIA) of This DOT

2 Disease(s) Related to This DOT
Disease Name Disease ID Evidence Level Mode of Inheritance REF
Neoplasm DISZKGEW Limited Altered Expression [1]
Neuroendocrine neoplasm DISNPLOO Limited Altered Expression [1]
------------------------------------------------------------------------------------
Molecular Interaction Atlas (MIA) Jump to Detail Molecular Interaction Atlas of This DOT
6 Drug(s) Affected the Gene/Protein Processing of This DOT
Drug Name Drug ID Highest Status Interaction REF
Valproate DMCFE9I Approved Valproate decreases the expression of Cysteine and tyrosine-rich protein 1 (CYYR1). [2]
Acetaminophen DMUIE76 Approved Acetaminophen increases the expression of Cysteine and tyrosine-rich protein 1 (CYYR1). [3]
Testosterone DM7HUNW Approved Testosterone decreases the expression of Cysteine and tyrosine-rich protein 1 (CYYR1). [4]
Ethanol DMDRQZU Approved Ethanol decreases the expression of Cysteine and tyrosine-rich protein 1 (CYYR1). [5]
Permethrin DMZ0Q1G Approved Permethrin decreases the expression of Cysteine and tyrosine-rich protein 1 (CYYR1). [6]
PMID28460551-Compound-2 DM4DOUB Patented PMID28460551-Compound-2 decreases the expression of Cysteine and tyrosine-rich protein 1 (CYYR1). [8]
------------------------------------------------------------------------------------
⏷ Show the Full List of 6 Drug(s)
1 Drug(s) Affected the Post-Translational Modifications of This DOT
Drug Name Drug ID Highest Status Interaction REF
Benzo(a)pyrene DMN7J43 Phase 1 Benzo(a)pyrene increases the methylation of Cysteine and tyrosine-rich protein 1 (CYYR1). [7]
------------------------------------------------------------------------------------

References

1 Sequence, "subtle" alternative splicing and expression of the CYYR1 (cysteine/tyrosine-rich 1) mRNA in human neuroendocrine tumors.BMC Cancer. 2007 Apr 18;7:66. doi: 10.1186/1471-2407-7-66.
2 Human embryonic stem cell-derived test systems for developmental neurotoxicity: a transcriptomics approach. Arch Toxicol. 2013 Jan;87(1):123-43.
3 Multiple microRNAs function as self-protective modules in acetaminophen-induced hepatotoxicity in humans. Arch Toxicol. 2018 Feb;92(2):845-858.
4 The exosome-like vesicles derived from androgen exposed-prostate stromal cells promote epithelial cells proliferation and epithelial-mesenchymal transition. Toxicol Appl Pharmacol. 2021 Jan 15;411:115384. doi: 10.1016/j.taap.2020.115384. Epub 2020 Dec 25.
5 Chronic ethanol exposure increases goosecoid (GSC) expression in human embryonic carcinoma cell differentiation. J Appl Toxicol. 2014 Jan;34(1):66-75.
6 Exposure to Insecticides Modifies Gene Expression and DNA Methylation in Hematopoietic Tissues In Vitro. Int J Mol Sci. 2023 Mar 26;24(7):6259. doi: 10.3390/ijms24076259.
7 Air pollution and DNA methylation alterations in lung cancer: A systematic and comparative study. Oncotarget. 2017 Jan 3;8(1):1369-1391. doi: 10.18632/oncotarget.13622.
8 Cell-based two-dimensional morphological assessment system to predict cancer drug-induced cardiotoxicity using human induced pluripotent stem cell-derived cardiomyocytes. Toxicol Appl Pharmacol. 2019 Nov 15;383:114761. doi: 10.1016/j.taap.2019.114761. Epub 2019 Sep 15.